Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT07402213 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Trial of JYB1904 Injection in Adult Patients With Chronic Spontaneous Urticaria.

StatusRecruiting
PhasePhase 3
SponsorJemincare
Started
View on ClinicalTrials.gov ↗

Record History

  1. Recruitment openedv2 Show 5 more changesShow less
    • Enrollment increased: 180 → 240 participants
    • Study completion pushed from Apr 28, 2028 to Jun 9, 2028
    • Study sites: 0 to 1
    • Primary completion date: Jun 30, 2027 to Jun 7, 2027
    • Start date changed from estimate of Mar 31, 2026 to Mar 9, 2026
  2. Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
Jemincare
23 trials monitored
See all monitored trials
This Phase III Trial is Meant to Evaluate the Efficacy, and Safety of JYB1904 Injection in Adult Patients With Chronic Spontaneous Urticaria.
Trial Details
NCT Number NCT07402213
Lead Sponsor Jemincare
Conditions
(from sponsor)		 Chronic Spontaneous Urticaria
Related terms Chronic Urticaria
Enrollment 240 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov